Cancer Family
Digestive System Neoplasm
CI-CAN-00000012Explore in graph →
Non-malignant4,732 active trials43 approved drugs557 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000012Explore in graph →
Clinical trials
22,051 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT06550453 | Safety and Efficacy of Pembrolizumab in Combination with Bevacizumab + CapeOX in the Neoadjuvant Treatment of RAS-mutated, BRAF Wild-type, Microsatellite-stabilized, Locally Advanced Colorectal Cancer | unknown | Phase 4 | 20 | yangjianjunOTHER | 1 | Nov 12, 2024 | clinicaltrials |
| NCT06590844 | "cindilizumab + Bevacizumab + Coenzyme I for Injection" in Unresectable Hepatocellular Carcinoma | unknown | Phase 4 | 37 | Anhui Provincial HospitalOTHER_GOV | 1 | Sep 19, 2024 |
| NCT06417606 | Lenvatinib and Adebrelimab Combined With GEMOX in the Perioperative Treatment of Potentially Resectable Intrahepatic Cholangiocarcinoma | unknown | Phase 4 | 20 | Zhiyong HuangOTHER | 1 | May 22, 2024 | clinicaltrials |
| NCT05661357 | Disitamab Vedotin Combined With Fruquintinib for mCRC With HER2 Expression(HCCSC-C03) | unknown | Phase 4 | 51 | Zhongnan HospitalOTHER | 1 | Apr 17, 2024 | clinicaltrials |
| NCT05124002 | Recombinant Human Adenovirus Type 5 Plus HAIC of FOLFOX for Intrahepatic Cholangiocarcinoma | unknown | Phase 4 | 66 | Beijing Tsinghua Chang Gung HospitalOTHER | 1 | Mar 4, 2024 | clinicaltrials |
| NCT06269445 | The Efficacy and Safety of Lcaritin Combined With Bevacizumab and FOLFIRI in Treatment of Liver Metastases From Colorectal Cancer | unknown | Phase 4 | 20 | Sir Run Run Shaw HospitalOTHER | 1 | Feb 21, 2024 | clinicaltrials |
| NCT06169410 | Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer | unknown | Phase 4 | 140 | Yang Jianjun, PhDOTHER | 1 | Jan 23, 2024 | clinicaltrials |
| NCT06115174 | Clinical Study Evaluating the Anticancer Effect of Pentoxiphylline in Patients With Metastatic Colorectal Cancer(CRC - PTX) | unknown | Phase 4 | 44 | Tanta UniversityOTHER | 0 | Nov 2, 2023 | clinicaltrials |
| NCT06003673 | A Clinical Study of Tislelizumab Combined With TACE and Lenvatinib in the Neoadjuvant Treatment of Resectable HCC | unknown | Phase 4 | 20 | First Affiliated Hospital of Fujian Medical UniversityOTHER | 1 | Oct 24, 2023 | clinicaltrials |
| NCT05926336 | The Effects of Using Different Anesthetics on the Prognosis of Primary Tumors and Its Mechanism of Action | unknown | Phase 4 | 1,316 | Kaohsiung Medical University Chung-Ho Memorial HospitalOTHER | 1 | Sep 28, 2023 | clinicaltrials |
| NCT05688020 | Tranexamic Acid During Upper GI Endoscopic Resection Procedures | unknown | Phase 4 | 200 | Assaf-Harofeh Medical CenterOTHER_GOV | 1 | Aug 9, 2023 | clinicaltrials |
| NCT05603065 | Tislelizumab With Chemotherapy or Radiation for Neoadjuvant Therapy of Esophageal Squamous Cell Carcinoma (TINES)(TINES) | unknown | Phase 4 | 32 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jun 29, 2023 | clinicaltrials |
| NCT05897749 | Clinical Study on the Effect of Brucea Javanica Oil Emulsion Injection on the Survival of Patients With Advanced Colorectal Cancer Who Failed to Receive Multi-line Treatment | unknown | Phase 4 | 60 | Guang'anmen Hospital of China Academy of Chinese Medical SciencesOTHER | 1 | Jun 9, 2023 | clinicaltrials |
| NCT04769713 | Hepatic Hilar Nerve Block Versus Sham in Pain Control During Liver Ablation and TACE Procedures | unknown | Phase 4 | 80 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Jun 2, 2023 | clinicaltrials |
| NCT02688699 | Additive Hemostatic Efficacy of EndoClot After EMR or ESD in the Gastrointestinal Tract | unknown | Phase 4 | 288 | University of Turin, ItalyOTHER | 0 | May 16, 2023 | clinicaltrials |
| NCT05670561 | Effects of Esketamine on Acute Abdominal Pain After TACE in Patients With Hepatocellular Carcinoma | unknown | Phase 4 | 60 | The Second Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Mar 29, 2023 | clinicaltrials |
| NCT02032953 | Enhancing the Anabolic Effect of Perioperative Nutrition With Insulin While Maintaining Normoglycemia | unknown | Phase 4 | 24 | McGill University Health Centre/Research Institute of the McGill University Health CentreOTHER | 1 | Mar 17, 2023 | clinicaltrials |
| NCT05768282 | Oral Prednisolone to Prevent Esophageal Stricture After RFA for Long-segment Esophageal Neoplasia | unknown | Phase 4 | 50 | E-DA HospitalOTHER | 1 | Mar 16, 2023 | clinicaltrials |
| NCT05416073 | Effect of Esketamine on Abdominal Pain During TACE-HAIC in Patients With Hepatocellular Carcinoma(TACE-HAIC) | unknown | Phase 4 | 70 | The Second Affiliated Hospital of Chongqing Medical UniversityOTHER | 1 | Feb 24, 2023 | clinicaltrials |
| NCT05645198 | The Effect of Carboxymetyl Starch (Oozfix) on Preventing Postoperative Complication After Gastrectomy(OOZFIX) | unknown | Phase 4 | 180 | Bucheon St. Mary's HospitalOTHER | 1 | Dec 9, 2022 | clinicaltrials |
| NCT05113290 | Effect and Safety of Recombinant Human Adenovirus Type 5 in Advanced HCC With Stable Disease After Sorafenib Treatment | unknown | Phase 4 | 66 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Jan 27, 2022 | clinicaltrials |
| NCT05068180 | Low-dose Neuroleptanalgesia for Postoperative Delirium in Elderly Patients | unknown | Phase 4 | 200 | RenJi HospitalOTHER | 1 | Oct 6, 2021 | clinicaltrials |
| NCT05067153 | Thromboprophylaxis in Oesophageal Cancer Patients(TOP-RCT) | unknown | Phase 4 | 100 | University of AarhusOTHER | 1 | Oct 5, 2021 | clinicaltrials |
| NCT04607057 | Supplemental Parenteral Nutrition During Postgastrectomy in Nutritionally at Risk Patient(SUPPORT) | unknown | Phase 4 | 224 | Seoul National University HospitalOTHER | 1 | Sep 24, 2021 | clinicaltrials |
| NCT05029453 | Apatinib Combined With Chemotherapy Versus Chemotherapy in Second-line Gastric Cancer Receiving Prior Anti-PD-1 Therapy | unknown | Phase 4 | 60 | Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyOTHER | 1 | Aug 31, 2021 | clinicaltrials |
| NCT04127396 | Lenvatinib Plus TACE Versus Sorafenib Plus TACE for HCC With PVTT | unknown | Phase 4 | 72 | Beijing Ditan HospitalOTHER | 1 | Jul 23, 2021 | clinicaltrials |
| NCT04810585 | Plasma Biomarker for Aflibercept in Advanced Colorectal Cancer | unknown | Phase 4 | 153 | Yonsei UniversityOTHER | 1 | Mar 23, 2021 | clinicaltrials |
| NCT04809935 | EUS-Coeliac Plexus Block Versus Radiofrequency Ablation in Pain Relief of Patients With Malignancy | unknown | Phase 4 | 54 | The University of Hong KongOTHER | 1 | Mar 22, 2021 | clinicaltrials |
| NCT04747951 | Total Neoadjuvant Therapy in Rectal Cancer Treatment | unknown | Phase 4 | 280 | State Scientific Centre of Coloproctology, Russian FederationOTHER_GOV | 1 | Feb 15, 2021 | clinicaltrials |
| NCT04709770 | Low-volume vs High-volume Polyethylene Glycol Based Bowel Preparation for Colonoscopy in People Receiving Hemodialysis(PrepDial) | unknown | Phase 4 | 264 | Alfredo Di LeoOTHER | 0 | Jan 14, 2021 | clinicaltrials |
| NCT03733639 | Tisseel® as a Reinforcement of Esophagojejunal Anastomoses | unknown | Phase 4 | 146 | Germans Trias i Pujol HospitalOTHER | 1 | Jul 23, 2020 | clinicaltrials |
| NCT04058236 | Glycocalyx Levels in Patients Undergoing Pancreatectomy | unknown | Phase 4 | 20 | University of MalayaOTHER | 1 | Apr 30, 2020 | clinicaltrials |
| NCT04357483 | Effect of Thrombin-containing Collagen-based Hemostatic Matrix(TCM) | unknown | Phase 4 | 60 | Asan Medical CenterOTHER | 1 | Apr 28, 2020 | clinicaltrials |
| NCT04269369 | Implementation of Pre-emptive Geno- and Phenotyping in 5-Fluorouracil- or Capecitabine-treated Patients | unknown | Phase 4 | 250 | Jessa HospitalOTHER | 0 | Feb 13, 2020 | clinicaltrials |
| NCT02504983 | Clinical Trial for GALNT14 Genotype - Guided, Sorafenib in Combination With TACE in Hepatocellular Carcinoma | unknown | Phase 4 | 200 | Chang Gung Memorial HospitalOTHER | 1 | Feb 5, 2020 | clinicaltrials |
| NCT04217096 | Efficacy and Safety of Paclitaxel Liposome and S-1 as First-line Therapy in \ Advanced Pancreatic Cancer Patients | unknown | Phase 4 | 40 | Fudan UniversityOTHER | 1 | Jan 3, 2020 | clinicaltrials |
| NCT01451658 | A Trial of EVL\GVS Alone vs. EVL\GVS Combined Propranolol (S-HCC) | unknown | Phase 4 | 100 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Sep 4, 2019 | clinicaltrials |
| NCT01970748 | Primary Prevention of Patients With Hepatocellular Carcinoma and Concomitant Esophageal Varices(P-HCC) | unknown | Phase 4 | 200 | Taipei Veterans General Hospital, TaiwanOTHER_GOV | 1 | Aug 30, 2019 | clinicaltrials |
| NCT02733809 | Mechanism of Sorafenib Resistance in Patients With Advanced Hepatocellular Carcinoma | unknown | Phase 4 | 40 | King Saud UniversityOTHER | 1 | Aug 20, 2019 | clinicaltrials |
| NCT03996681 | TACE Combined With Methylcantharidimide Tablets in the Treatment of Large and Unresectable Hepatocellular Carcinoma | unknown | Phase 4 | 22 | Suzhou Municipal HospitalOTHER | 1 | Jun 25, 2019 | clinicaltrials |
| NCT03843229 | Clinical Trial of Cinobufacini Combined With Transarterial Chemoembolization (TACE) on Primary Liver Cancer | unknown | Phase 4 | 90 | The First Affiliated Hospital of Dalian Medical UniversityOTHER | 1 | Feb 18, 2019 | clinicaltrials |
| NCT01271582 | Investigation of Association Between UGT1A1 Polymorphisms and Irinotecan Toxicity in Korean Patients | unknown | Phase 4 | 1,500 | Asan Medical CenterOTHER | 1 | Jan 29, 2019 | clinicaltrials |
| NCT02933333 | G-CSF Alone or Combination With GM-CSF on Prevention and Treatment of Infection in Children With Malignant Tumor | unknown | Phase 4 | 405 | Xinhua Hospital, Shanghai Jiao Tong University School of MedicineOTHER | 1 | Oct 17, 2018 | clinicaltrials |
| NCT03642093 | HOPE - A Study to Evaluate the Effect of a Prehabilitation Program on GI Cancer Patients Planning to Undergo Surgery(HOPE) | unknown | Phase 4 | 60 | Siobhan TrotterOTHER | 1 | Sep 11, 2018 | clinicaltrials |
| NCT02243735 | Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia(FIT) | unknown | Phase 4 | 198 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 28, 2018 | clinicaltrials |
| NCT02138981 | Hepatectomy Versus Chemoembolization for Resectable Hepatocellular Carcinoma Beyond Milan Criteria | unknown | Phase 4 | 436 | Sun Yat-sen UniversityOTHER | 1 | Aug 2, 2018 | clinicaltrials |
| NCT03518502 | Sorafenib Monotherapy vs. TACE-sorafenib Sequential Therapy for HCC With Metastasis | unknown | Phase 4 | 130 | Korea UniversityOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT03515369 | Effect of Babaodan on Tumor Recurrence After Curative Resection of Hepatocellular Carcinoma | unknown | Phase 4 | 459 | Eastern Hepatobiliary Surgery HospitalOTHER | 0 | May 3, 2018 | clinicaltrials |
| NCT03465202 | Association of Capecitabine Pharmacokinetics and Toxicity With Aging | unknown | Phase 4 | 100 | Newcastle-upon-Tyne Hospitals NHS TrustOTHER | 0 | Mar 14, 2018 | clinicaltrials |
Data updated 22 days agoSource updated Nov 12, 2024source: clinicaltrials